SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shilpa Medicare has submitted its Annual Secretarial Compliance Report for the financial year ended 31 March 2025, filed under SEBI's Listing Regulations (Regulation 24A). The report, prepared by Practicing Company Secretary D.S. Rao, confirms that the company has fully complied with all applicable SEBI regulations and circulars during the year. No deviations, penalties, or observations were flagged across all 13 compliance parameters checked, including secretarial standards, related party transactions, insider trading, disclosures, and website maintenance. No action was taken against the company, its promoters, directors, or subsidiaries by SEBI or the stock exchanges during the review period.
This is a routine regulatory filing confirming clean compliance with SEBI rules for FY25, which is mildly positive for corporate governance but is unlikely to move the stock price as it carries no new business or financial information.